IFP Advisors Inc Has $3.02 Million Stock Holdings in HCA Healthcare, Inc. $HCA

IFP Advisors Inc trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 18.6% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 7,843 shares of the company’s stock after selling 1,795 shares during the period. IFP Advisors Inc’s holdings in HCA Healthcare were worth $3,022,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Cheviot Value Management LLC bought a new stake in shares of HCA Healthcare in the 1st quarter valued at about $26,000. Saudi Central Bank bought a new stake in shares of HCA Healthcare in the 1st quarter valued at about $26,000. WPG Advisers LLC bought a new stake in shares of HCA Healthcare in the 1st quarter valued at about $27,000. Ameriflex Group Inc. bought a new stake in shares of HCA Healthcare in the 2nd quarter valued at about $27,000. Finally, Chung Wu Investment Group LLC bought a new stake in shares of HCA Healthcare in the 2nd quarter valued at about $27,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 1.30% of the stock is owned by corporate insiders.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $414.73 on Friday. The company’s 50 day simple moving average is $405.12 and its 200 day simple moving average is $375.58. The stock has a market capitalization of $97.04 billion, a price-to-earnings ratio of 17.43, a price-to-earnings-growth ratio of 1.32 and a beta of 1.40. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $439.01.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. The business had revenue of $18.61 billion for the quarter, compared to analysts’ expectations of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period last year, the firm posted $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th were paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is 12.11%.

Wall Street Analyst Weigh In

Several research analysts have weighed in on HCA shares. UBS Group set a $465.00 price target on shares of HCA Healthcare in a report on Wednesday. Cantor Fitzgerald reissued an “overweight” rating and issued a $444.00 price target on shares of HCA Healthcare in a report on Tuesday. Royal Bank Of Canada lowered their price target on shares of HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating on the stock in a report on Monday, July 28th. Wolfe Research cut shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a report on Monday, July 28th. Finally, Robert W. Baird raised their target price on shares of HCA Healthcare from $380.00 to $423.00 and gave the stock a “neutral” rating in a report on Thursday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $422.31.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.